Paul Perreault
Chief Executive Officer chez CSL Behring AB
Fortune : 31 M $ au 31/03/2024
Profil
Actuellement, Paul Roger Perreault est directeur général, directeur exécutif et directeur général de CSL Ltd. Au cours de sa carrière passée, il a occupé le poste de président du conseil d'administration de la Plasma Protein Therapeutics Association, de directeur général et de directeur exécutif de CSL Behring LLC, de vice-président et de directeur général d'Aventis Behring, de directeur commercial de Wyeth-Ayerst Research et de vice-président et de directeur général d'Aventis Bio-Services, Inc. M. Perreault est titulaire d'un diplôme de premier cycle de l'université de Floride centrale.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
CSL LIMITED
0,03% | 30/06/2023 | 165 301 ( 0,03% ) | 31 M $ | 31/03/2024 |
Postes actifs de Paul Perreault
Sociétés | Poste | Début |
---|---|---|
CSL Behring AB
CSL Behring AB Pharmaceuticals: MajorHealth Technology CSL Behring AB develops, manufactures, and markets protein-based therapies in the bleeding disorders, critical care, immunoglobulins, and pulmonary areas. It offers therapies such as plasma-derived and recombinant coagulation factors, immunoglobulins for the treatment of primary immune deficiency, alpha1-proteinase inhibitor for chronic A1-PI augmentation therapy, and C1-INH concentrate. The company was founded in 1904 and is headquartered in Danderyd, Sweden. | Chief Executive Officer | - |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Director/Board Member | 01/12/2020 |
CSL Finance Plc
CSL Finance Plc Finance/Rental/LeasingFinance Part of CSL Ltd., CSL Finance Plc provides finance services for group companies. The private company is based in Haywards Heath, UK. The British company was founded in 2002. The CEO is Paul Roger Perreault. | Chief Executive Officer | - |
Anciens postes connus de Paul Perreault
Sociétés | Poste | Fin |
---|---|---|
CSL LIMITED | Chief Executive Officer | 06/03/2023 |
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | Chairman | - |
Aventis Behring | Corporate Officer/Principal | - |
Aventis Bio-Services, Inc.
Aventis Bio-Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Aventis Bio-Services, Inc. develops pharmaceutical and agricultural products. The private company is based in King of Prussia, PA. | Corporate Officer/Principal | - |
Wyeth-Ayerst Research | Corporate Officer/Principal | - |
Formation de Paul Perreault
University of Central Florida | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CSL LIMITED | Health Technology |
Entreprise privées | 8 |
---|---|
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | Commercial Services |
Aventis Bio-Services, Inc.
Aventis Bio-Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Aventis Bio-Services, Inc. develops pharmaceutical and agricultural products. The private company is based in King of Prussia, PA. | Health Technology |
Aventis Behring | Health Technology |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
Wyeth-Ayerst Research | |
CSL Behring AB
CSL Behring AB Pharmaceuticals: MajorHealth Technology CSL Behring AB develops, manufactures, and markets protein-based therapies in the bleeding disorders, critical care, immunoglobulins, and pulmonary areas. It offers therapies such as plasma-derived and recombinant coagulation factors, immunoglobulins for the treatment of primary immune deficiency, alpha1-proteinase inhibitor for chronic A1-PI augmentation therapy, and C1-INH concentrate. The company was founded in 1904 and is headquartered in Danderyd, Sweden. | Health Technology |
CSL Finance Plc
CSL Finance Plc Finance/Rental/LeasingFinance Part of CSL Ltd., CSL Finance Plc provides finance services for group companies. The private company is based in Haywards Heath, UK. The British company was founded in 2002. The CEO is Paul Roger Perreault. | Finance |